Search by Drug Name or NDC

    NDC 00002-1506-80 MOUNJARO 2.5 mg/.5mL Details

    MOUNJARO 2.5 mg/.5mL

    MOUNJARO is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is TIRZEPATIDE.

    Product Information

    NDC 00002-1506
    Product ID 0002-1506_b597917f-9673-4331-809d-79a538bb943c
    Associated GPIs 2717308000D210
    GCN Sequence Number 083391
    GCN Sequence Number Description tirzepatide PEN INJCTR 2.5 MG/0.5 SUBCUT
    HIC3 C4Z
    HIC3 Description ANTIHYPERGLYCEMIC - INCRETIN MIMETICS COMBINATION
    GCN 52336
    HICL Sequence Number 048014
    HICL Sequence Number Description TIRZEPATIDE
    Brand/Generic Brand
    Proprietary Name MOUNJARO
    Proprietary Name Suffix n/a
    Non-Proprietary Name tirzepatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/.5mL
    Substance Name TIRZEPATIDE
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215866
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-1506-80 (00002150680)

    NDC Package Code 0002-1506-80
    Billing NDC 00002150680
    Package 4 SYRINGE in 1 CARTON (0002-1506-80) / .5 mL in 1 SYRINGE (0002-1506-01)
    Marketing Start Date 2022-05-13
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 467.366
    Pricing Unit ML
    Effective Date 2022-08-17
    NDC Description MOUNJARO 2.5 MG/0.5 ML PEN
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 2, 5
    Classification for Rate Setting B
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis